DOES ADJUVANT CHEMOTHERAPY BENEFIT HIGH-RISK STAGE 2 COLON CANCER: A NOMOGRAM TO PREDICT REDUCTION IN 5-YEAR MORTALITY RISK WITH ADJUVANT CHEMOTHERAPY.

被引：0
|
作者：
Graham, A. E.
Sparks, A.
Umapathi, B.
机构：
来源：
DISEASES OF THE COLON & RECTUM | 2019年 / 62卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P36
引用
收藏
页码：E121 / E122
页数：2
相关论文
共 50 条
  • [31] ROLE FOR ADJUVANT CHEMOTHERAPY FOR EARLY STAGE COLON CANCER WITH HIGH-RISK FEATURES AFTER SURGICAL RESECTION.
    Wood, E.
    Kalu, R. U.
    Tang, A.
    Reickert, C.
    Nalamati, S.
    Asai, M.
    DISEASES OF THE COLON & RECTUM, 2020, 63 (06) : E435 - E435
  • [32] No evidence for adjuvant chemotherapy in high-risk disease
    Peter Albers
    Nature Reviews Urology, 2015, 12 : 602 - 603
  • [33] No evidence for adjuvant chemotherapy in high-risk disease
    Albers, Peter
    NATURE REVIEWS UROLOGY, 2015, 12 (11) : 602 - 603
  • [34] Neoadjuvant and adjuvant chemotherapy for high-risk localized prostate cancer
    Nakabayashi M.
    Oh W.K.
    Current Treatment Options in Oncology, 2004, 5 (5) : 349 - 355
  • [35] Adjuvant chemotherapy in high-risk liposarcomas.
    Loehmer, Philipp
    Gronchi, Alessandro
    Brodowicz, Thomas
    Stoeckle, Eberhard
    Callegaro, Dario
    Coindre, Jean -Michel
    Podleska, Lars
    Lamm, Wolfgang
    Fiore, Marco
    Cousin, Sophie
    Treckmann, Juergen
    Schur, Sophie
    Radaelli, Stefano
    Toulmonde, Maud
    Reis, Anna-Carinna
    Colombo, Chiara
    Pottgen, Christoph
    Eisele, Lewin
    Italiano, Antoine
    Bauer, Sebastian
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial
    Aoki, Y
    Watanabe, M
    Amikura, T
    Obata, H
    Sekine, M
    Yahata, T
    Fujita, K
    Tanaka, K
    GYNECOLOGIC ONCOLOGY, 2004, 94 (02) : 333 - 339
  • [37] Adjuvant chemotherapy provided survival benefit for stage T2N0 gastric cancer with high-risk factors
    Wang, Z.
    Yan, J.
    Hu, W.
    Zhang, J.
    Huo, B.
    NEOPLASMA, 2018, 65 (04) : 592 - 598
  • [38] Effect of Adjuvant Chemotherapy on Elderly Stage II High-Risk Colorectal Cancer Patients
    Lee, Yujin
    Park, Inseok
    Cho, Hyunjin
    Gwak, Geumhee
    Yang, Keunho
    Bae, Byung-Noe
    ANNALS OF COLOPROCTOLOGY, 2021, 37 (05) : 298 - 305
  • [39] High-risk nonmetastatic prostate cancer in the elderly: Does adjuvant chemotherapy affect survival?
    Akhtar, Komal
    Formica, Margaret K.
    Madhira, Bhaskara
    Basnet, Alina
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [40] Impact of adjuvant chemotherapy on recurrence risk in stage II colon cancer.
    Adesoye, Taiwo
    Hu, Chung-Yuan
    Cuddy, Amanda
    Francescatti, Amanda B.
    Schumacher, Jessica R.
    You, Y. Nancy
    Van Loon, Katherine
    Schrag, Deborah
    McKellar, Daniel P.
    Winchester, David Porter
    Chang, George J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
12345